Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • 232 Pages
From
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 83 Pages
From
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 81 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

  • Drug Pipelines
  • 781 Pages
From
Indolent Lymphoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Review, H1 2015

  • Drug Pipelines
  • 173 Pages
From
Bioavailability Enhancement Technologies and Services Market, 2018-2030 - Product Thumbnail Image

Bioavailability Enhancement Technologies and Services Market, 2018-2030

  • Report
  • 300 Pages
From
Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

  • Report
  • 200 Pages
From
Pharmaceutical Contract Manufacturing Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Contract Manufacturing Market (2nd Edition), 2018-2028

  • Report
  • 520 Pages
From
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018 - Product Thumbnail Image

Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 74 Pages
From
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 74 Pages
From
Computer-Aided Drug Discovery Services Market, 2018-2030 - Product Thumbnail Image

Computer-Aided Drug Discovery Services Market, 2018-2030

  • Report
  • 315 Pages
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • 225 Pages
From
Nanotechnology in Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Nanotechnology in Drug Delivery - Global Strategic Business Report

  • Report
  • 202 Pages
From
Biologics Market Global Briefing 2018 - Product Thumbnail Image

Biologics Market Global Briefing 2018

  • Report
  • 34 Pages
From
Injury Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Injury Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 148 Pages
From
Pharmaceutical Industry Business Outlook and Procurement Report H1 2016 - Product Thumbnail Image

Pharmaceutical Industry Business Outlook and Procurement Report H1 2016

  • Report
  • 44 Pages
From
Q1 2017 Earnings Call - Eagle Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q1 2017 Earnings Call - Eagle Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q3 2016 Earnings Call - Eagle Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2016 Earnings Call - Eagle Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Eagle Pharmaceuticals Inc (EGRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Eagle Pharmaceuticals Inc (EGRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • 84 Pages
From
Loading Indicator
adroll